{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:19:29Z","timestamp":1791591569164,"version":"4.3.4"},"reference-count":116,"publisher":"Springer Science and Business Media LLC","issue":"17","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100018822","name":"Western Sydney University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018822","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s40265-023-01951-z","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T09:01:58Z","timestamp":1697187718000},"page":"1571-1579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["The Place of Cannabinoids in the Treatment of Gynecological Pain"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9960-3191","authenticated-orcid":false,"given":"Justin","family":"Sinclair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Proudfoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7539-9851","authenticated-orcid":false,"given":"Mike","family":"Armour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"key":"1951_CR1","unstructured":"Gynecological diseases - Level 3 cause. Institute for Health Metrics and Evaluation. 2019; https:\/\/www.healthdata.org\/results\/gbd_summaries\/2019\/gynecological-diseases-level-3-cause#:~:text=Summary%20Gynaecological%20diseases%20caused%20a,with%20gynaecological%20diseases%20in%202019. Accessed 3 June 2023."},{"issue":"8","key":"1951_CR2","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1089\/jwh.2018.7615","volume":"28","author":"M Armour","year":"2019","unstructured":"Armour M, et al. The prevalence and academic impact of dysmenorrhea in 21,573 young women: a systematic review and meta-analysis. J Womens Health (Larchmt). 2019;28(8):1161\u201371.","journal-title":"J Womens Health (Larchmt)"},{"issue":"2","key":"1951_CR3","first-page":"489","volume":"60","author":"AS Coco","year":"1999","unstructured":"Coco AS. Primary dysmenorrhea. Am Fam Physician. 1999;60(2):489\u201396.","journal-title":"Am Fam Physician"},{"issue":"7550","key":"1951_CR4","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1136\/bmj.332.7550.1134","volume":"332","author":"M Proctor","year":"2006","unstructured":"Proctor M, Farquhar C. Diagnosis and management of dysmenorrhoea. BMJ. 2006;332(7550):1134\u20138.","journal-title":"BMJ"},{"issue":"2","key":"1951_CR5","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1097\/01.AOG.0000230214.26638.0c","volume":"108","author":"MY Dawood","year":"2006","unstructured":"Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Obstet Gynecol. 2006;108(2):428\u201341.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"1951_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pop.2008.10.004","volume":"36","author":"C Morrow","year":"2009","unstructured":"Morrow C, Naumburg EH. Dysmenorrhea. Prim Care. 2009;36(1):19\u201332 (vii).","journal-title":"Prim Care"},{"issue":"3","key":"1951_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.contraception.2009.09.014","volume":"81","author":"HP Zahradnik","year":"2010","unstructured":"Zahradnik HP, Hanjalic-Beck A, Groth K. Nonsteroidal anti-inflammatory drugs and hormonal contraceptives for pain relief from dysmenorrhea: a review. Contraception. 2010;81(3):185\u201396.","journal-title":"Contraception"},{"issue":"5","key":"1951_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jpag.2020.06.007","volume":"33","author":"M Armour","year":"2020","unstructured":"Armour M, et al. The prevalence and educational impact of pelvic and menstrual pain in Australia: a National Online Survey of 4202 Young Women Aged 13\u201325 Years. J Pediatr Adolesc Gynecol. 2020;33(5):511\u20138.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"1951_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1471-0528.2009.02407.x","volume":"117","author":"MA Parker","year":"2010","unstructured":"Parker MA, Sneddon AE, Arbon P. The menstrual disorder of teenagers (MDOT) study: determining typical menstrual patterns and menstrual disturbance in a large population-based study of Australian teenagers. BJOG. 2010;117(2):185\u201392.","journal-title":"BJOG"},{"issue":"6","key":"1951_CR10","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026186","volume":"9","author":"ME Schoep","year":"2019","unstructured":"Schoep ME, et al. Productivity loss due to menstruation-related symptoms: a nationwide cross-sectional survey among 32 748 women. BMJ Open. 2019;9(6): e026186.","journal-title":"BMJ Open"},{"issue":"5","key":"1951_CR11","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.3390\/ijerph18052260","volume":"18","author":"K Holmes","year":"2021","unstructured":"Holmes K, et al. Adolescent Menstrual Health Literacy in Low, Middle and High-Income Countries: A Narrative Review. Int J Environ Res Public Health. 2021;18(5):2260.","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"1951_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jpag.2020.11.007","volume":"34","author":"M Armour","year":"2021","unstructured":"Armour M, et al. Menstrual Health Literacy and Management Strategies in Young Women in Australia: a National Online Survey of Young Women Aged 13\u201325 Years. J Pediatr Adolesc Gynecol. 2021;34(2):135\u201343.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"3","key":"1951_CR13","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/ijerph19031536","volume":"19","author":"J Sinclair","year":"2022","unstructured":"Sinclair J, et al. Should I inhale?;Perceptions, barriers, and drivers for medicinal cannabis use amongst australian women with primary dysmenorrhoea: a qualitative study. Int J Environ Res Public Health. 2022;19(3):1536.","journal-title":"Int J Environ Res Public Health"},{"key":"1951_CR14","volume-title":"Pelvic pain: diagnosis and management","author":"F Howard","year":"2000","unstructured":"Howard F, et al. Pelvic pain: diagnosis and management. Philadelphia: Lippincott Williams and Wilkins; 2000."},{"key":"1951_CR15","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/09593535221083846","volume":"32","author":"A Hawkey","year":"2022","unstructured":"Hawkey A, et al. \u201cA day-to-day struggle\u201d: A comparative qualitative study on experiences of women with endometriosis and chronic pelvic pain. Femin Psychol. 2022;32:482\u2013500.","journal-title":"Femin Psychol"},{"issue":"1","key":"1951_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1472-6874-14-123","volume":"14","author":"M Moradi","year":"2014","unstructured":"Moradi M, et al. Impact of endometriosis on women\u2019s lives: a qualitative study. BMC Womens Health. 2014;14(1):123.","journal-title":"BMC Womens Health"},{"issue":"1","key":"1951_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/ajo.13458","volume":"62","author":"M Armour","year":"2022","unstructured":"Armour M, et al. Endometriosis and the workplace: lessons from Australia\u2019s response to COVID-19. Aust N Z J Obstet Gynaecol. 2022;62(1):164\u20137.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"23","key":"1951_CR18","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1001\/jama.2021.2631","volume":"325","author":"G Lamvu","year":"2021","unstructured":"Lamvu G, et al. Chronic pelvic pain in women: a review. JAMA. 2021;325(23):2381\u201391.","journal-title":"JAMA"},{"issue":"1","key":"1951_CR19","doi-asserted-by":"publisher","first-page":"16253","DOI":"10.1038\/s41598-020-73389-2","volume":"10","author":"M Armour","year":"2020","unstructured":"Armour M, et al. Endometriosis and chronic pelvic pain have similar impact on women, but time to diagnosis is decreasing: an Australian survey. Sci Rep. 2020;10(1):16253.","journal-title":"Sci Rep"},{"issue":"2","key":"1951_CR20","doi-asserted-by":"publisher","first-page":"E141","DOI":"10.36076\/ppj.2014\/17\/E141","volume":"17","author":"A Ahangari","year":"2014","unstructured":"Ahangari A. Prevalence of chronic pelvic pain among women: an updated review. Pain Physician. 2014;17(2):E141\u20137.","journal-title":"Pain Physician"},{"issue":"2","key":"1951_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1097\/AOG.0000000000004656","volume":"139","author":"AL Liang","year":"2022","unstructured":"Liang AL, Gingher EL, Coleman JS. Medical cannabis for gynecologic pain conditions: a systematic review. Obstet Gynecol. 2022;139(2):287\u201396.","journal-title":"Obstet Gynecol"},{"issue":"10","key":"1951_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0223316","volume":"14","author":"M Armour","year":"2019","unstructured":"Armour M, et al. The cost of illness and economic burden of endometriosis and chronic pelvic pain in Australia: A national online survey. PLoS ONE. 2019;14(10): e0223316.","journal-title":"PLoS ONE"},{"key":"1951_CR23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1752","volume":"348","author":"M Hickey","year":"2014","unstructured":"Hickey M, Ballard K, Farquhar C. Endometriosis. BMJ. 2014;348: g1752.","journal-title":"BMJ"},{"issue":"7","key":"1951_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220103","volume":"14","author":"M Armour","year":"2019","unstructured":"Armour M, et al. Self-care strategies and sources of knowledge on menstruation in 12,526 young women with dysmenorrhea: A systematic review and meta-analysis. PLoS ONE. 2019;14(7): e0220103.","journal-title":"PLoS ONE"},{"issue":"12","key":"1951_CR25","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1111\/imj.15494","volume":"52","author":"S Evans","year":"2022","unstructured":"Evans S, et al. Treatment use and satisfaction in Australian women with endometriosis: a mixed-methods study. Intern Med J. 2022;52(12):2096\u2013106.","journal-title":"Intern Med J"},{"issue":"6","key":"1951_CR26","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.fertnstert.2006.11.051","volume":"87","author":"N Sinaii","year":"2007","unstructured":"Sinaii N, et al. Treatment utilization for endometriosis symptoms: a cross-sectional survey study of lifetime experience. Fertil Steril. 2007;87(6):1277\u201386.","journal-title":"Fertil Steril"},{"key":"1951_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13696998.2019.1707212","volume":"23","author":"S As-Sanie","year":"2020","unstructured":"As-Sanie S, et al. Healthcare utilization and cost burden among women with endometriosis by opioid prescription status in the first year after diagnosis: a retrospective claims database analysis. J Med Econ. 2020;23:1\u20137.","journal-title":"J Med Econ"},{"key":"1951_CR28","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/pds.5209","volume":"30","author":"SE Chiuve","year":"2021","unstructured":"Chiuve SE, et al. Chronic opioid use and complication risks in women with endometriosis: a cohort study in US administrative claims. Pharmacoepidemiol Drug Saf. 2021;30:787\u201396.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1951_CR29","unstructured":"Armour M, et al. Lessons from implementing the Australian National Action Plan for Endometriosis. Reproduction and Fertility, 2022: p. RAF-22-0003."},{"key":"1951_CR30","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.fertnstert.2023.05.156","volume":"120","author":"H Roman","year":"2023","unstructured":"Roman H, et al. Long-term risk of repeated surgeries in women managed for endometriosis: a 1,092 patient-series. Fertil Steril. 2023;120:870\u20139.","journal-title":"Fertil Steril"},{"issue":"10085","key":"1951_CR31","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1016\/S0140-6736(17)31344-2","volume":"389","author":"AW Horne","year":"2017","unstructured":"Horne AW, et al. Top ten endometriosis research priorities in the UK and Ireland. Lancet. 2017;389(10085):2191\u20132.","journal-title":"Lancet"},{"issue":"2","key":"1951_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1177\/1933719116654991","volume":"24","author":"PA Rogers","year":"2017","unstructured":"Rogers PA, et al. Research priorities for endometriosis. Reprod Sci. 2017;24(2):202\u201326.","journal-title":"Reprod Sci"},{"key":"1951_CR33","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/ajo.13699","volume":"63","author":"M Armour","year":"2023","unstructured":"Armour M, et al. Endometriosis research priorities in Australia. Aust N Z J Obstet Gynaecol. 2023;63:594\u20138.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"8","key":"1951_CR34","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1002\/cbdv.200790144","volume":"4","author":"EB Russo","year":"2007","unstructured":"Russo EB. History of cannabis and its preparations in saga, science, and sobriquet. Chem Biodivers. 2007;4(8):1614\u201348.","journal-title":"Chem Biodivers"},{"key":"1951_CR35","volume-title":"Cannabis evolution and ethnobotany","author":"R Clarke","year":"2013","unstructured":"Clarke R, Merlin MD. Cannabis evolution and ethnobotany. Berkeley: University of California Press; 2013."},{"issue":"2","key":"1951_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1590\/S1516-44462006000200015","volume":"28","author":"AW Zuardi","year":"2006","unstructured":"Zuardi AW. History of cannabis as a medicine: a review. Rev Bras Psiquiatr. 2006;28(2):153\u20137.","journal-title":"Rev Bras Psiquiatr"},{"issue":"3\u20134","key":"1951_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1300\/J175v02n03_02","volume":"2","author":"EB Russo","year":"2002","unstructured":"Russo EB. Cannabis treatments in obstetrics and gynecology: a historical review. J Cannabis Therap. 2002;2(3\u20134):5\u201335.","journal-title":"J Cannabis Therap"},{"key":"1951_CR38","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/02791072.1981.10471447","volume":"13","author":"M Touwn","year":"1981","unstructured":"Touwn M. The religious and medicinal uses of Cannabis in China, india and Tibet. J Psychoactive Drugs. 1981;13:23\u201334.","journal-title":"J Psychoactive Drugs"},{"key":"1951_CR39","volume-title":"Essays on the puerperal fever and other diseases peculiar to women","author":"F Churchill","year":"1849","unstructured":"Churchill F. Essays on the puerperal fever and other diseases peculiar to women. London: Sydenham Society; 1849."},{"key":"1951_CR40","unstructured":"Christison A. On the natural history, action, and uses of Indian Hemp. Mon J Med Sci. 1851;4(19):26\u201345."},{"key":"1951_CR41","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1056\/NEJM185909290610902","volume":"61","author":"I Willis","year":"1859","unstructured":"Willis I. Cannabis indica. Boston Med Surg J. 1859;61:173\u20138.","journal-title":"Boston Med Surg J"},{"key":"1951_CR42","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1136\/bmj.1.1169.1002","volume":"1","author":"J Brown","year":"1883","unstructured":"Brown J. Cannabis indica; A valuable remedy in menorrhagia. BMJ. 1883;1:1002.","journal-title":"BMJ"},{"key":"1951_CR43","first-page":"225","volume":"2","author":"H Hare","year":"1887","unstructured":"Hare H. Clinical and physiological notes on the action of Cannabis indica. Therapeutic Gazette. 1887;2:225\u20138.","journal-title":"Therapeutic Gazette"},{"key":"1951_CR44","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/095952874302600116","volume":"26","author":"J Clendinning","year":"1843","unstructured":"Clendinning J. Observation on the medicinal properties of Cannabis sativa from India. Medico-Chirurg Trans. 1843;26:188\u2013210.","journal-title":"Medico-Chirurg Trans"},{"key":"1951_CR45","first-page":"23","volume-title":"Handbook of Cannabis","author":"E Russo","year":"2016","unstructured":"Russo E. The pharmacological history of cannabis. In: Pertwee R, editor. Handbook of Cannabis. Oxford: Oxford University Press; 2016. p. 23\u201343."},{"key":"1951_CR46","volume-title":"The elements of materia medica and therapeutics","author":"P Pereira","year":"1843","unstructured":"Pereira P. The elements of materia medica and therapeutics. Philadelphia: Lea & Blanchard; 1843."},{"key":"1951_CR47","first-page":"1","volume-title":"Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential","author":"M Fankhauser","year":"2002","unstructured":"Fankhauser M. History of cannabis in Western Medicine. In: Grotenhermen F, Russo E, editors. Cannabis and cannabinoids: pharmacology, toxicology, and therapeutic potential. New York: Hawthorn Integrative Healing Press; 2002. p. 1\u2013439."},{"issue":"3","key":"1951_CR48","first-page":"180","volume":"42","author":"MB Bridgeman","year":"2017","unstructured":"Bridgeman MB, Abazia DT. Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting. P T. 2017;42(3):180\u20138.","journal-title":"P T"},{"key":"1951_CR49","first-page":"54","volume":"32","author":"J Sinclair","year":"2020","unstructured":"Sinclair J, Adams C, Thurgood G-R, Davidson M, Armour M, Sarris J. Cannabidiol (CBD) oil: Rehashing the research, roles and regulations in Australia. Austra J Herb Naturopathic Med. 2020;32:54\u201360.","journal-title":"Austra J Herb Naturopathic Med"},{"key":"1951_CR50","first-page":"83","volume":"11","author":"S Duke","year":"2010","unstructured":"Duke S. Cannabis captiva: freeing the world from marijuana prohibition. Georgetown J Int Affairs. 2010;11:83\u201390.","journal-title":"Georgetown J Int Affairs"},{"key":"1951_CR51","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1021\/ja01062a046","volume":"86","author":"Y Gaoni","year":"1964","unstructured":"Gaoni Y, Mechoulam R. Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc. 1964;86:1646\u20137.","journal-title":"J Am Chem Soc"},{"issue":"3","key":"1951_CR52","doi-asserted-by":"publisher","first-page":"223","DOI":"10.31887\/DCNS.2020.22.3\/mcrocq","volume":"22","author":"MA Crocq","year":"2020","unstructured":"Crocq MA. History of cannabis and the endocannabinoid system. Dialogues Clin Neurosci. 2020;22(3):223\u20138.","journal-title":"Dialogues Clin Neurosci"},{"issue":"2","key":"1951_CR53","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.nbd.2009.10.023","volume":"37","author":"A Castillo","year":"2010","unstructured":"Castillo A, et al. The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors. Neurobiol Dis. 2010;37(2):434\u201340.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1951_CR54","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1124\/jpet.109.159145","volume":"332","author":"NA Jones","year":"2010","unstructured":"Jones NA, et al. Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo. J Pharmacol Exp Ther. 2010;332(2):569\u201377.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"1951_CR55","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/npp.2011.6","volume":"36","author":"MM Bergamaschi","year":"2011","unstructured":"Bergamaschi MM, et al. Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients. Neuropsychopharmacology. 2011;36(6):1219\u201326.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"1951_CR56","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1476-5381.2009.00521.x","volume":"159","author":"TV Zanelati","year":"2010","unstructured":"Zanelati TV, et al. Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors. Br J Pharmacol. 2010;159(1):122\u20138.","journal-title":"Br J Pharmacol"},{"issue":"10","key":"1951_CR57","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.freeradbiomed.2011.02.021","volume":"50","author":"P Mukhopadhyay","year":"2011","unstructured":"Mukhopadhyay P, et al. Cannabidiol protects against hepatic ischemia\/reperfusion injury by attenuating inflammatory signaling and response, oxidative\/nitrative stress, and cell death. Free Radic Biol Med. 2011;50(10):1368\u201381.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1951_CR58","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/antiox9010021","volume":"9","author":"S Atalay","year":"2019","unstructured":"Atalay S, Jarocka-Karpowicz I, Skrzydlewska E. Antioxidative and anti-inflammatory properties of cannabidiol. Antioxidants (Basel). 2019;9(1):21.","journal-title":"Antioxidants (Basel)"},{"issue":"4","key":"1951_CR59","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.nurt.2009.08.002","volume":"6","author":"EJ Rahn","year":"2009","unstructured":"Rahn EJ, Hohmann AG. Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside. Neurotherapeutics. 2009;6(4):713\u201337.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"1951_CR60","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00213-005-2242-2","volume":"181","author":"M Haney","year":"2005","unstructured":"Haney M, et al. Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology. 2005;181(1):170\u20138.","journal-title":"Psychopharmacology"},{"issue":"11","key":"1951_CR61","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1177\/1352458510378020","volume":"16","author":"RB Kavia","year":"2010","unstructured":"Kavia RB, et al. Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis. Mult Scler. 2010;16(11):1349\u201359.","journal-title":"Mult Scler"},{"issue":"7","key":"1951_CR62","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","volume":"163","author":"EB Russo","year":"2011","unstructured":"Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344\u201364.","journal-title":"Br J Pharmacol"},{"issue":"12","key":"1951_CR63","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1039\/C6NP00074F","volume":"33","author":"LO Hanus","year":"2016","unstructured":"Hanus LO, et al. Phytocannabinoids: a unified critical inventory. Nat Prod Rep. 2016;33(12):1357\u201392.","journal-title":"Nat Prod Rep"},{"issue":"9","key":"1951_CR64","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/febs.12260","volume":"280","author":"P Pacher","year":"2013","unstructured":"Pacher P, Kunos G. Modulating the endocannabinoid system in human health and disease\u2013successes and failures. FEBS J. 2013;280(9):1918\u201343.","journal-title":"FEBS J"},{"issue":"3","key":"1951_CR65","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089566","volume":"9","author":"JM McPartland","year":"2014","unstructured":"McPartland JM, Guy GW, Di Marzo V. Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system. PLoS ONE. 2014;9(3): e89566.","journal-title":"PLoS ONE"},{"key":"1951_CR66","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.pnpbp.2015.03.006","volume":"64","author":"RJ Henry","year":"2016","unstructured":"Henry RJ, et al. For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2016;64:167\u201380.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"1951_CR67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13048-018-0478-9","volume":"12","author":"OS Walker","year":"2019","unstructured":"Walker OS, Holloway AC, Raha S. The role of the endocannabinoid system in female reproductive tissues. J Ovarian Res. 2019;12(1):3.","journal-title":"J Ovarian Res"},{"issue":"8","key":"1951_CR68","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.1016\/j.fertnstert.2010.02.006","volume":"93","author":"D Gentilini","year":"2010","unstructured":"Gentilini D, et al. Endocannabinoid system regulates migration of endometrial stromal cells via cannabinoid receptor 1 through the activation of PI3K and ERK1\/2 pathways. Fertil Steril. 2010;93(8):2588\u201393.","journal-title":"Fertil Steril"},{"issue":"1","key":"1951_CR69","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JME-12-0182","volume":"50","author":"AM Di Blasio","year":"2013","unstructured":"Di Blasio AM, Vignali M, Gentilini D. The endocannabinoid pathway and the female reproductive organs. J Mol Endocrinol. 2013;50(1):R1-9.","journal-title":"J Mol Endocrinol"},{"issue":"8","key":"1951_CR70","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1177\/1933719116630414","volume":"23","author":"AM Sanchez","year":"2016","unstructured":"Sanchez AM, et al. Elevated systemic levels of endocannabinoids and related mediators across the menstrual cycle in women with endometriosis. Reprod Sci. 2016;23(8):1071\u20139.","journal-title":"Reprod Sci"},{"issue":"3","key":"1951_CR71","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.pain.2010.08.037","volume":"151","author":"N Dmitrieva","year":"2010","unstructured":"Dmitrieva N, et al. Endocannabinoid involvement in endometriosis. Pain. 2010;151(3):703\u201310.","journal-title":"Pain"},{"issue":"12","key":"1951_CR72","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1093\/molehr\/gas037","volume":"18","author":"AM Sanchez","year":"2012","unstructured":"Sanchez AM, et al. The molecular connections between the cannabinoid system and endometriosis. Mol Hum Reprod. 2012;18(12):563\u201371.","journal-title":"Mol Hum Reprod"},{"issue":"1","key":"1951_CR73","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1089\/can.2016.0035","volume":"2","author":"J Bouaziz","year":"2017","unstructured":"Bouaziz J, et al. The clinical significance of endocannabinoids in endometriosis pain management. Cannabis Cannabinoid Res. 2017;2(1):72\u201380.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"4","key":"1951_CR74","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/humupd\/dmaa005","volume":"26","author":"J Maia","year":"2020","unstructured":"Maia J, et al. The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders. Hum Reprod Update. 2020;26(4):586\u2013602.","journal-title":"Hum Reprod Update"},{"issue":"12","key":"1951_CR75","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1177\/1933719119833483","volume":"26","author":"X Shen","year":"2019","unstructured":"Shen X, et al. Expression of cannabinoid receptors in myometrium and its correlation with dysmenorrhea in adenomyosis. Reprod Sci. 2019;26(12):1618\u201325.","journal-title":"Reprod Sci"},{"issue":"2","key":"1951_CR76","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nn.3612","volume":"17","author":"D Piomelli","year":"2014","unstructured":"Piomelli D, Sasso O. Peripheral gating of pain signals by endogenous lipid mediators. Nat Neurosci. 2014;17(2):164\u201374.","journal-title":"Nat Neurosci"},{"issue":"3","key":"1951_CR77","first-page":"399","volume":"2","author":"AS Rice","year":"2001","unstructured":"Rice AS. Cannabinoids and pain. Curr Opin Investig Drugs. 2001;2(3):399\u2013414.","journal-title":"Curr Opin Investig Drugs"},{"issue":"1","key":"1951_CR78","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1089\/can.2017.0017","volume":"2","author":"KP Hill","year":"2017","unstructured":"Hill KP, et al. Cannabis and pain: a clinical review. Cannabis Cannabinoid Res. 2017;2(1):96\u2013104.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"4","key":"1951_CR79","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S0306-4522(00)00389-4","volume":"100","author":"J Ahluwalia","year":"2000","unstructured":"Ahluwalia J, et al. Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience. 2000;100(4):685\u20138.","journal-title":"Neuroscience"},{"issue":"1","key":"1951_CR80","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/15504263.2019.1668100","volume":"16","author":"AL Milligan","year":"2020","unstructured":"Milligan AL, Szabo-Pardi TA, Burton MD. Cannabinoid receptor type 1 and its role as an analgesic: an opioid alternative? J Dual Diagn. 2020;16(1):106\u201319.","journal-title":"J Dual Diagn"},{"issue":"3","key":"1951_CR81","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/22840265211011277","volume":"13","author":"I Marcu","year":"2021","unstructured":"Marcu I, Gee A, Lynn B. Cannabinoids and chronic pelvic pain in women: focus on endometriosis. J Endomet aPelvic Pain Disord. 2021;13(3):155\u201365.","journal-title":"J Endomet aPelvic Pain Disord"},{"issue":"6","key":"1951_CR82","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/187152709789824660","volume":"8","author":"J Guindon","year":"2009","unstructured":"Guindon J, Hohmann AG. The endocannabinoid system and pain. CNS Neurol Disord Drug Targets. 2009;8(6):403\u201321.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"8","key":"1951_CR83","doi-asserted-by":"publisher","first-page":"3093","DOI":"10.1073\/pnas.0409888102","volume":"102","author":"MM Ibrahim","year":"2005","unstructured":"Ibrahim MM, et al. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci U S A. 2005;102(8):3093\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1951_CR84","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2174\/157015906778019527","volume":"4","author":"J Manzanares","year":"2006","unstructured":"Manzanares J, Julian M, Carrascosa A. Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes. Curr Neuropharmacol. 2006;4(3):239\u201357.","journal-title":"Curr Neuropharmacol"},{"issue":"18","key":"1951_CR85","doi-asserted-by":"publisher","first-page":"10529","DOI":"10.1073\/pnas.1834309100","volume":"100","author":"MM Ibrahim","year":"2003","unstructured":"Ibrahim MM, et al. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci U S A. 2003;100(18):10529\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1951_CR86","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fnmol.2018.00487","volume":"11","author":"C Muller","year":"2018","unstructured":"Muller C, Morales P, Reggio PH. Cannabinoid ligands targeting TRP channels. Front Mol Neurosci. 2018;11:487.","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"1951_CR87","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/jcp.20954","volume":"211","author":"S Pisanti","year":"2007","unstructured":"Pisanti S, et al. Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy. J Cell Physiol. 2007;211(2):495\u2013503.","journal-title":"J Cell Physiol"},{"issue":"6","key":"1951_CR88","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.2353\/ajpath.2010.100375","volume":"177","author":"M Leconte","year":"2010","unstructured":"Leconte M, et al. Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis. Am J Pathol. 2010;177(6):2963\u201370.","journal-title":"Am J Pathol"},{"key":"1951_CR89","doi-asserted-by":"publisher","first-page":"1153584","DOI":"10.3389\/fphar.2023.1153584","volume":"14","author":"H Clarke","year":"2023","unstructured":"Clarke H, Fitzcharles M. The evolving culture of medical cannabis in Canada for the management of chronic pain. Front Pharmacol. 2023;14:1153584.","journal-title":"Front Pharmacol"},{"key":"1951_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103307","volume":"97","author":"D Perkins","year":"2021","unstructured":"Perkins D, et al. Medicinal cannabis and driving: the intersection of health and road safety policy. Int J Drug Policy. 2021;97: 103307.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"1951_CR91","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/ajo.13642","volume":"63","author":"M Armour","year":"2023","unstructured":"Armour M, Sinclair J. Cannabis for endometriosis-related pain and symptoms: It\u2019s high time that we see this as a legitimate treatment. Aust N Z J Obstet Gynaecol. 2023;63(1):118\u201320.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"9","key":"1951_CR92","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1089\/jwh.2020.8737","volume":"30","author":"AR Carrubba","year":"2021","unstructured":"Carrubba AR, et al. Use of cannabis for self-management of chronic pelvic pain. J Womens Health (Larchmt). 2021;30(9):1344\u201351.","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"1951_CR93","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12906-019-2431-x","volume":"19","author":"M Armour","year":"2019","unstructured":"Armour M, et al. Self-management strategies amongst Australian women with endometriosis: a national online survey. BMC Complement Altern Med. 2019;19(1):17.","journal-title":"BMC Complement Altern Med"},{"key":"1951_CR94","doi-asserted-by":"publisher","unstructured":"Sinclair J, Smith CA, Abbott J, Chalmers KJ, Pate DW, Armour M. Cannabis use, a self-management strategy among australian women with endometriosis: results from a National Online Survey. J Obstet Gynaecol Can. 2020;42:256\u201361. https:\/\/doi.org\/10.1016\/j.jogc.2019.08.033.","DOI":"10.1016\/j.jogc.2019.08.033"},{"issue":"10","key":"1951_CR95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258940","volume":"16","author":"J Sinclair","year":"2021","unstructured":"Sinclair J, et al. Effects of cannabis ingestion on endometriosis-associated pelvic pain and related symptoms. PLoS ONE. 2021;16(10): e0258940.","journal-title":"PLoS ONE"},{"key":"1951_CR96","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejim.2018.01.004","volume":"49","author":"CA MacCallum","year":"2018","unstructured":"MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. Eur J Intern Med. 2018;49:12\u20139.","journal-title":"Eur J Intern Med"},{"issue":"4","key":"1951_CR97","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1089\/can.2021.0162","volume":"7","author":"M Armour","year":"2022","unstructured":"Armour M, et al. Endometriosis and cannabis consumption during the COVID-19 pandemic: an international cross-sectional survey. Cannabis Cannabinoid Res. 2022;7(4):473\u201381.","journal-title":"Cannabis Cannabinoid Res"},{"issue":"10","key":"1951_CR98","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1089\/jwh.2020.8668","volume":"30","author":"M Armour","year":"2021","unstructured":"Armour M, et al. Illicit cannabis usage as a management strategy in New Zealand women with endometriosis: an online survey. J Womens Health (Larchmt). 2021;30(10):1485\u201392.","journal-title":"J Womens Health (Larchmt)"},{"issue":"4","key":"1951_CR99","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1089\/can.2021.0116","volume":"7","author":"J Sinclair","year":"2022","unstructured":"Sinclair J, et al. Cannabis use for endometriosis: clinical and legal challenges in Australia and New Zealand. Cannabis Cannabinoid Res. 2022;7(4):464\u201372.","journal-title":"Cannabis Cannabinoid Res"},{"key":"1951_CR100","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejim.2021.05.002","volume":"89","author":"CA MacCallum","year":"2021","unstructured":"MacCallum CA, Lo LA, Boivin M. \u201cIs medical cannabis safe for my patients?\u201d A practical review of cannabis safety considerations. Eur J Intern Med. 2021;89:10\u20138.","journal-title":"Eur J Intern Med"},{"issue":"11","key":"1951_CR101","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/j.1360-0443.1994.tb03743.x","volume":"89","author":"H Petursson","year":"1994","unstructured":"Petursson H. The benzodiazepine withdrawal syndrome. Addiction. 1994;89(11):1455\u20139.","journal-title":"Addiction"},{"issue":"5","key":"1951_CR102","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/jcpt.13114","volume":"45","author":"JV Pergolizzi Jr","year":"2020","unstructured":"Pergolizzi JV Jr, Raffa RB, Rosenblatt MH. Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management. J Clin Pharm Ther. 2020;45(5):892\u2013903.","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"1951_CR103","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s42238-020-00056-8","volume":"2","author":"M Reid","year":"2020","unstructured":"Reid M. A qualitative review of cannabis stigmas at the twilight of prohibition. J Cannabis Res. 2020;2(1):46.","journal-title":"J Cannabis Res"},{"issue":"12","key":"1951_CR104","doi-asserted-by":"publisher","first-page":"7499","DOI":"10.3390\/ijerph19127499","volume":"19","author":"LJ Troup","year":"2022","unstructured":"Troup LJ, et al. Perceived stigma of patients undergoing treatment with cannabis-based medicinal products. Int J Environ Res Public Health. 2022;19(12):7499.","journal-title":"Int J Environ Res Public Health"},{"key":"1951_CR105","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1477-7517-10-2","volume":"10","author":"JL Bottorff","year":"2013","unstructured":"Bottorff JL, et al. Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study. Harm Reduct J. 2013;10:2.","journal-title":"Harm Reduct J"},{"issue":"3","key":"1951_CR106","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.3390\/ijerph19031536","volume":"19","author":"J Sinclair","year":"2022","unstructured":"Sinclair J, et al. \u201cShould I Inhale?\u201d-perceptions, barriers, and drivers for medicinal cannabis use amongst Australian women with primary dysmenorrhoea: a qualitative study. Int J Environ Res Public Health. 2022;19(3):1536.","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"1951_CR107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0155113","volume":"11","author":"S Isaac","year":"2016","unstructured":"Isaac S, Saini B, Chaar BB. The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists\u2019 Perspectives. PLoS ONE. 2016;11(5): e0155113.","journal-title":"PLoS ONE"},{"issue":"3","key":"1951_CR108","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/ijpp\/riac005","volume":"30","author":"Q Sabmeethavorn","year":"2022","unstructured":"Sabmeethavorn Q, Bonomo YA, Hallinan CM. Pharmacists\u2019 perceptions and experiences of medicinal cannabis dispensing: a narrative review with a systematic approach. Int J Pharm Pract. 2022;30(3):204\u201314.","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"1951_CR109","doi-asserted-by":"publisher","DOI":"10.1111\/ijn.12836","volume":"27","author":"S Melnikov","year":"2021","unstructured":"Melnikov S, et al. The effect of attitudes, subjective norms and stigma on health-care providers\u2019 intention to recommend medicinal cannabis to patients. Int J Nurs Pract. 2021;27(1): e12836.","journal-title":"Int J Nurs Pract"},{"key":"1951_CR110","first-page":"1","volume":"1","author":"T Clobes","year":"2022","unstructured":"Clobes T, Palmier LA, Gagnon M, Klaiman C, Arellano M. The impact of education on attitudes toward medical cannabis. PEC Innovation. 2022;1:1\u20135.","journal-title":"PEC Innovation"},{"issue":"3","key":"1951_CR111","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1136\/jfprhc-2013-100853","volume":"41","author":"K Young","year":"2015","unstructured":"Young K, Fisher J, Kirkman M. Women\u2019s experiences of endometriosis: a systematic review and synthesis of qualitative research. J Fam Plann Reprod Health Care. 2015;41(3):225\u201334.","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"1","key":"1951_CR112","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/ajo.12571","volume":"57","author":"K Young","year":"2017","unstructured":"Young K, Fisher J, Kirkman M. Clinicians\u2019 perceptions of women\u2019s experiences of endometriosis and of psychosocial care for endometriosis. Aust N Z J Obstet Gynaecol. 2017;57(1):87\u201392.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"11","key":"1951_CR113","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/ajim.23170","volume":"63","author":"J Howard","year":"2020","unstructured":"Howard J, Osborne J. Cannabis and work: need for more research. Am J Ind Med. 2020;63(11):963\u201372.","journal-title":"Am J Ind Med"},{"key":"1951_CR114","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neubiorev.2021.01.003","volume":"126","author":"D McCartney","year":"2021","unstructured":"McCartney D, et al. Determining the magnitude and duration of acute Delta(9)-tetrahydrocannabinol (Delta(9)-THC)-induced driving and cognitive impairment: a systematic and meta-analytic review. Neurosci Biobehav Rev. 2021;126:175\u201393.","journal-title":"Neurosci Biobehav Rev"},{"key":"1951_CR115","unstructured":"Therapeutic Goods Order No. 93 (Standard for Medicinal Cannabis). Australian Federal Government. Department of Health: Canberra, ACT Australia; 2017."},{"key":"1951_CR116","first-page":"55","volume-title":"Cannabis inflorescence","year":"2013","unstructured":"Upton R, ElSohly M, Romm A, Russo E, Sexton M, editors. Cannabis inflorescence. Scotts Valley: American Herbal Pharmacopoeia; 2013. p. 55."}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-023-01951-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40265-023-01951-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-023-01951-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,2]],"date-time":"2023-12-02T11:10:35Z","timestamp":1701515435000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40265-023-01951-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":116,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1951"],"URL":"https:\/\/doi.org\/10.1007\/s40265-023-01951-z","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"20 September 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open Access funding enabled and organized by CAUL and its Member InstitutionS. JS PhD is supported by a Western Sydney University Post-Graduate Research Scholarship; however, no specific funding was provided for preparing this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"As a medical research institute, NICM Health Research Institute (at Western Sydney University) receives research grants and donations from foundations, universities, government agencies, and industry. Sponsors and donors provide united and tied funding for work to advance the vision and mission of the Institute. JS is employed by Australian Natural Therapeutics Group, and formerly sat on the scientific advisory board for BioCeuticals. JS is also a current member of the scientific advisory board for United in Compassion (<i>pro bono<\/i>) and a board member of the Australian Medicinal Cannabis Association (<i>pro bono<\/i>). JA reports grant funding from MRFF for multiple endometriosis-related research grants; honoraria, member on Advisory Boards with Hologic Australia and CSL Vifor (formerly Vifor Pharma Pty. Ltd.); is a member of the Endometriosis Advisory Group to the Australian Government, Chairs the Expert Endometriosis Working Group for the Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG), was the chair for the publication of the Diagnosis and Management of Endometriosis Clinical Guideline in 2021; and is the Deputy Editor of the Journal of Minimally Invasive Gynecology and Associate Editor of the Australian and New Zealand Journal of Obstetrics and Gynaecology. MA is an advisory board member for Evolv Health, reports grant funding from MRFF for multiple endometriosis-related research grants, is chair of Endometriosis Australia\u2019s Clinical Advisory Committee, and is a member of the Expert Endometriosis Working Group for the Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). AP declares that they have no conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"JS and MA wrote the main manuscript. JA and AP provided feedback to the main manuscript. All authors reviewed the manuscript prior to submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent (Participation & Publication)"}},{"value":"Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}